2022, Volume 15, Issue 11, pp 1431 – 1436

Retinopathy of prematurity, a two-year experience at the ROP screening unit from AL-Zahraa Teaching Hospital, AL-Najaf, Iraq

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Corresponding Author: Alaa Jumaah Manji Nasrawi, Department of Pediatrics, College of Medicine, University of Kufa, Kufa, Iraq. E-mail: alaaj.nasrawi@uokufa.edu.iq

Abstract

This study aimed to assess the incidence of retinopathy of prematurity (ROP) in Al Najaf city, define the risk factors of ROP, and assess the performance of the newly implemented ROP screening. This retrospective study was performed in the ROP screening clinic in Al Najaf city between January 2018 and December 2019. 247 neonates were examined at the ROP screening clinic, with gestational age ≤30 weeks, weight ≤1500 g, other fetal and maternal risk factors, and older or heavier newborns with a complicated course. Out of all the neonates, 90 were enrolled in this study because all others lost contact with the ROP clinic. 62 out of 90 enrolled neonates (69%) were diagnosed with ROP. Of them, 82% had stage 1–2 ROP, and 18% had stage 3–4. We found that the higher gestational age was protective for ROP (P-value=0.012, OR=0.434, CI=0.227–0.829). CPAP carried a higher risk of ROP (P-value=0.072, OR=7.276, CI=0.834–63.441). The P-value was significant for maternal age and premature rupture of membranes (PROM) (P-value=0.028 and 0.01, respectively). This study showed the incidence of ROP in the accepted range compared to other countries with similar resources. Furthermore, there was a strong association between ROP and the following factors: decreased gestational age, CPAP, maternal age, and PROM.

Keywords

About this article

PMC ID: 9762363
PubMed ID: 36567829
DOI: 10.25122/jml-2022-0060

Article Publishing Date (print): 11 2022
Available Online: 

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues